AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Short Interest Up 90.8% in August

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) was the recipient of a large growth in short interest in August. As of August 31st, there was short interest totaling 873,918 shares, a growth of 90.8% from the August 15th total of 458,107 shares. Based on an average daily volume of 476,023 shares, the short-interest ratio is currently 1.8 days. Approximately 3.5% of the shares of the stock are short sold.

AGF U.S. Market Neutral Anti-Beta Fund Stock Down 0.8%

BTAL traded down $0.10 during trading on Thursday, hitting $12.39. The company’s stock had a trading volume of 1,017,531 shares, compared to its average volume of 796,786. The stock has a market capitalization of $312.23 million, a price-to-earnings ratio of 17.67 and a beta of -0.64. The firm’s 50 day moving average price is $12.08 and its two-hundred day moving average price is $12.43. AGF U.S. Market Neutral Anti-Beta Fund has a 12 month low of $10.86 and a 12 month high of $16.14.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Crescent Grove Advisors LLC bought a new stake in AGF U.S. Market Neutral Anti-Beta Fund during the 1st quarter worth about $6,614,000. PMV Capital Advisers LLC raised its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 14.0% in the first quarter. PMV Capital Advisers LLC now owns 246,621 shares of the company’s stock worth $3,443,000 after acquiring an additional 30,234 shares during the last quarter. Worth Asset Management LLC lifted its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 20.5% during the first quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock worth $425,000 after purchasing an additional 5,190 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 59.4% during the first quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after purchasing an additional 10,146 shares in the last quarter. Finally, CoreCap Advisors LLC bought a new stake in shares of AGF U.S. Market Neutral Anti-Beta Fund during the second quarter valued at approximately $36,000.

AGF U.S. Market Neutral Anti-Beta Fund Company Profile

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.